John Bell

Researcher

Related Research

Related News & Events

Research Highlight|May 14, 2019

TFRI-funded scientists publish snapshot on oncolytic viruses in top scientific journal

Members of a long-standing TFRI team focused on developing cancer-killing viruses have published a snapshot article summarizing this promising area of...

Research Highlight|September 10, 2018

Scientists use protein found in mosquito virus to suppress RNAi pathway, opening door to make oncolytic viruses more effective

By using a protein from a virus first found in Japanese mosquitoes in the 1950s, TFRI-funded researchers have discovered a new way to bypass antiviral...

TFRI News|February 08, 2018

2017 Marathon of Hope Lecture Series

As part of its 10th anniversary celebration, TFRI presented a session titled The Marathon of Hope Lecture Series at the Canadian Cancer Research Confe...

Research Highlight|January 03, 2018

New study shows viruses and checkpoint inhibitors work together to cure resistant breast cancer in mice

A new study led by TFRI-funded researchers at The Ottawa Hospital (TOH) and the University of Ottawa suggests that a combination of two immunotherapie...

TFRI News|September 06, 2017

Four premier TFRI investigators will present Marathon of Hope talks at CCRC

TFRI is pleased to announce that it will be presenting a concurrent session (D6 in program) at the upcoming Canadian Cancer Research Conference featur...

Press Release|September 05, 2017

Three 2017 PPG awards announced for cutting-edge projects in leukemia, oncolytic viruses, nanoparticle imaging

The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs).

Research Highlight|May 24, 2017

Complement inhibitors decrease neutralization of some oncolytic viruses, increase treatment efficacy

The use of oncolytic viruses to stimulate a patient’s immune system as well as directly kill tumour cells is a novel approach to eradicating cancer, b...

In the Media|July 10, 2015

Canadian study to use two cancer-fighting viruses in world first

Ontario researchers have launched the first clinical trial that will use two, custom-made, cancer-fighting viruses to stimulate the immune system into...

Research Highlight|July 10, 2015

Cancer patients treated in world-first clinical trial of viral therapy

Terry Fox-funded researchers are key members of a Canadian team to have launched the world’s first clinical trial of a new therapy that uses a combina...

All News & Events